Does MACITENTAN Cause Myelofibrosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Myelofibrosis have been filed in association with MACITENTAN (OPSYNVI). This represents 0.0% of all adverse event reports for MACITENTAN.
5
Reports of Myelofibrosis with MACITENTAN
0.0%
of all MACITENTAN reports
4
Deaths
1
Hospitalizations
How Dangerous Is Myelofibrosis From MACITENTAN?
Of the 5 reports, 4 (80.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
Which MACITENTAN Alternatives Have Lower Myelofibrosis Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE